In the context of a Lanham Act case, CRA assessed whether market performance for a hospital-based pharmaceutical product was affected by alleged improper statements by a competitor. CRA’s causality analysis included consideration of other economic factors that affected product sales, including assessment of market preparation, launch, commercialization, and promotional efforts used to support the product that was allegedly affected by improper marketing support.
CRA named Top 3 Litigation Dispute Advisory Services Consultant in The National Law Journal
CRA’s Chicago Practice is proud to have been ranked as one of the Top 3 Litigation Dispute Advisory Services Consultancies in The National Law Journal’s “Best...